Bluejay Diagnostics Inc
NASDAQ:BJDX
Bluejay Diagnostics Inc
NASDAQ:BJDX
Price:
0.5289 USD
5.57%
Updated:
May 2, 2024
Bluejay Diagnostics Inc
Cash from Financing Activities
|
Bluejay Diagnostics Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bluejay Diagnostics Inc
NASDAQ:BJDX
|
Cash from Financing Activities
$1.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Bluejay Diagnostics Inc's Cash from Financing Activities?
Cash from Financing Activities
1.1m
USD
1.1m
USD
Based on the financial report for Dec 31, 2023, Bluejay Diagnostics Inc's Cash from Financing Activities amounts to 1.1m USD.
What is Bluejay Diagnostics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-6%
-6%
Over the last year, the Cash from Financing Activities growth was 11 016%. The average annual Cash from Financing Activities growth rates for Bluejay Diagnostics Inc have been -6% over the past three years .
You don't have any saved screeners yet
